Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 15.32M
June 30, 2026 15.75M
March 31, 2026 22.53M
December 31, 2025 27.67M
September 30, 2025 -43.92M
June 30, 2025 -41.84M
March 31, 2025 -36.46M
December 31, 2024 -46.26M
September 30, 2024 -40.24M
June 30, 2024 -64.34M
March 31, 2024 -50.30M
December 31, 2023 -38.60M
September 30, 2023 -29.47M
Date Value
June 30, 2023 -22.13M
March 31, 2023 -12.18M
December 31, 2022 -5.033M
September 30, 2022 -10.68M
June 30, 2022 -1.369M
March 31, 2022 6.559M
December 31, 2021 13.52M
September 30, 2021 7.859M
June 30, 2021 14.97M
March 31, 2021 16.44M
December 31, 2020 20.83M
September 30, 2020 -74.90M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -105.37M
Amgen, Inc. 14.35B
Anika Therapeutics, Inc. 137.58M
BioCryst Pharmaceuticals, Inc. -397.38M
Imunon, Inc. 2.622M

Shareholders Equity (Quarterly) Related Metrics